Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Slides:

Advertisements

Similar presentations

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà

Advertisements

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Primary care of hypertensive patients and the risk of acute events Irina Stirbu-Wagner Markus MJ Nielen Maaike Langelaan Robert A. Verheij Joke C. Korevaar.

Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Evaluating depression in type 2 diabetes comorbidities in Romanian patients - implications for hypertensive patients Vladut Ioana Corina, MA Center for.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Influence of Comorbid Depression and Antidepressant Treatment on Mortality for Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease by SSDI-eligibility.

Comorbidities and Diabetes Care – Impact on Treatment Strategies Dr. Joel Rodriguez-Saldana Multidisciplinary Diabetes Centres Mexico.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Association of C-Reactive Protein and Acute Myocardial Infarction in HIV-Infected Patients Virginia A. Triant, MD, MPH, James B. Meigs, MD, MPH, and Steven.

Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.

Diabetes: 0–44 years Ranked comorbidity combinations Source: ABS Australian Health Survey 2011–12 (National Health Survey component) For people aged 0–44,

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Use of Inhaled Corticosteroids and the Risk.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.

Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Inflammatory Biomarkers and Exacerbations in Chronic.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.

The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.

Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates.

R. Papani, A. G. Duarte, Y-L. Lin, G. Sharma

Table 1. Baseline Characteristics of the 36,636 Study Subjects

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Volume 97, Issue 8, Pages (August 2003)

Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma Willem M.C. van Aalderen, MD, PhD, Jonathan Grigg,

The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD

Least squares (LS) mean change from baseline (95% CI) in St George's Respiratory Questionnaire (SGRQ) Total score according to previous chronic obstructive.

An Interprofessional Approach to the Patient With Chronic Airway Disease.

Primary data collection versus use of retrospective claims data: methodology lessons learned from a linked database study in chronic obstructive pulmonary.

Ventilatory and cerebrovascular responses to hyperoxic hypercapnia.

Summary findings regarding the efficacy/safety profile across xanthines in chronic obstructive pulmonary disease patients. a) Combined plot of the change.

Relationship between the change in a) ventilatory and b) cerebrovascular responses in older healthy subjects (Older) and chronic obstructive pulmonary.

Prevalence of true-positive, false-negative and false-positive cases of chronic obstructive pulmonary disease identified with the fixed-limit Global Initiative.

Influence of do-not-resuscitate (DNR) order specification on overall survival in chronic obstructive pulmonary disease (COPD) patients (log rank test p

Comorbidity status in patients with CKD stage 4 or 5 not on dialysis, peritoneal dialysis, haemodialysis and transplanted patients (bars), as well as in.

Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.

Venn diagram showing the overlap between the various chronic obstructive pulmonary disease (COPD) diagnoses: self-reported physician-diagnosed, fixed ratio.

Classification of statins/dosages according to the attainable

Prevalence (x axis) of disease groups (DGs) (y axis) in the population of Medicare (light cyan) and Catalan Healthcare Surveillance System (CHSS) (light.

Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care by Bosco Baron-Franco, Gary McLean, Frances S Mair,

Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.

Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.

Prevalence of comorbidities in pooled studies of patients with chronic obstructive pulmonary disease (COPD). Prevalence of comorbidities in pooled studies.

a) Mortality per time point (p<0

3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).

Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.

Benefit–risk balance and its individual determinants with personalised chronic obstructive pulmonary disease (COPD) treatment choices. Benefit–risk balance.

Time to death from diabetes diagnosis for propensity-matched sample adjusted for age, gender, race, and other conditions. Time to death from diabetes diagnosis.

Forest plot meta-analysis of the impact of long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations on changes in.

Respiratory Unit Questions

Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.

Screening test accuracy of the final risk score at a threshold of ≥2

Distribution of patients in the first- or second-year follow-up according to the number of acute exacerbations of chronic obstructive pulmonary disease.

Schematic diagram of the shared subgroups between asthma and chronic obstructive pulmonary disease (COPD). Schematic diagram of the shared subgroups between.

Forest plot from meta-analysis carried out on four studies including high-dose N-acetylcysteine (NAC) treatment a) assessing the relative risk of chronic.

Fig. 1. Linear-by-linear association of chronic rhinosinusitis and recurrent rhinosinusitis in obstructive sleep apnea syndrome according to age. Linear-by-linear.

Prevalence of acute myocardial infarction (AMI) or other cardiovascular events (CVEs) according to a) Pneumonia Severity Index (PSI) risk classes and b)

Comparison of exhaled H2O2 values in chronic obstructive pulmonary disease (COPD) patients (n=12) and control group (n=9). a) Raw ambient air concentrations.

The natural history of chronic obstructive pulmonary disease (COPD) is a mixture of the natural history of the various phenotypes making up the umbrella.

Presentation transcript:

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà dell’autore e fornito come supporto didattico per uso personale.

The prevalenceofasthma and COPD in Italy M. Cazzola, E. Puxeddu, G. Bettoncelli, L. Novelli, A. Segreti, C. Cricelli, L. Calzetta - Respiratory Medicine (2011)

Prevalence of comorbidities in the general population and in asthmatic patients

Odds ratios and 95% confidence limits of comorbidities in asthma according to sex. p<0.05 vs. general population

Odds ratios and 95% confidence limits of comorbidities in asthma according to age. p<0.05 vs. general population

Asthma and ComorbidMedicalIllnessMarioCazzola a,b, Luigino Calzetta a, Germano Bettoncelli c, Lucia Novelli a, Claudio Cricelli c, Paola Rogliani a (ERJ 2010) RESULTS: Apparently, asthma was a weak risk factor for cardiovascular and hypertensive diseases. Intriguingly, the OR of acute or old myocardial infarction was 0.84 (95% CI ). Asthma was a weak risk factor also of depression, diabetes mellitus, dyslipidaemia, osteoporosis, and rhinosinusitis. On the contrary, it was an important risk factor for gastroesophageal reflux disease and, mainly, allergic rhinitis. Age did not influence the risk of asthma-induced comorbidities whereas gender had a different impact according to the specific comorbidity. CONCLUSIONS: Our results indicate that asthma is a risk factor for these comorbid conditions

Figure 1 – People with and without COPD who reported cardiovascular comorbidities, by age group and gender (% of the examined population). Without COPD: solid square: total; solid circle:men; solid triangles: women. With COPD: open square: total;open circle:men;open triangles: women. Prevalence of Comorbidities in Patients with Chronic Obstructive Pulmonary Disease. Cazzola MCazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Respiration Feb 4. [Epub ahead of printBettoncelli GSessa ECricelli CBiscione G

Prevalence of Comorbidities in Patients with Chronic Obstructive Pulmonary Disease. Cazzola MCazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Respiration Feb 4. [Epub ahead of print]Bettoncelli GSessa ECricelli CBiscione G Figure 2 – People with and without COPD who reported other selected comorbidities, by age group and gender (% of the examined population). Without COPD: solid square: total; solid circle:men; solid triangles: women.With COPD: open square: total; open circle:men;open triangles: women.

Boyd CM, Darer J, Boult C, et al. Clinicalpractice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294:

Prescriptions of drugsforobstructiveairwaydiseases (ATC code R03).

Drug prescription for asthma and COPD by general practitioners in Italy: is it changing in a very short time? Mario Cazzola 1, Andrea Segreti 1, Germano Bettoncelli 2, Luigino Calzetta 1, Claudio Cricelli 2, Franco Pasqua 3, Paola Rogliani 1 PCRJ 2011 Compared to 2006, in 2008 there were increased prescriptions of ß 2 -agonist/inhaled corticosteroid fixed combination in asthma but only 54.5% of all prescriptions included an inhaled corticosteroid. This could explain the largeuseofshort-acting ß 2 -agonists, a marker of poor asthma control. Remarkably, ß 2 - agonist/inhaled corticosteroid fixed combinations were prescribed more frequently in COPD than in asthma. Our data indicate that adherence to guidelines is still low and patients with asthma and COPD are undertreatedby Italian GPs, with a trend to a change mainly in COPD likely driven by new scientific information

Changes in prescriptions of drugs forobstructiveairwaydiseases (ATC code R03) in COPD between 2006 and For each group of drugs, the % of prescriptions considering the total number of prescriptions for that group and year is reported. ICSs, inhaled corticosteroids